• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症:分子医学与公共卫生的交汇。

Primary aldosteronism: molecular medicine meets public health.

机构信息

Department of Medicine, Faculty of Medicine, The National University of Malaysia (UKM), Kuala Lumpur, Malaysia.

Endocrine Hypertension, Department of Clinical Pharmacology and Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

出版信息

Nat Rev Nephrol. 2023 Dec;19(12):788-806. doi: 10.1038/s41581-023-00753-6. Epub 2023 Aug 23.

DOI:10.1038/s41581-023-00753-6
PMID:37612380
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7615304/
Abstract

Primary aldosteronism is the most common single cause of hypertension and is potentially curable when only one adrenal gland is the culprit. The importance of primary aldosteronism to public health derives from its high prevalence but huge under-diagnosis (estimated to be <1% of all affected individuals), despite the consequences of poor blood pressure control by conventional therapy and enhanced cardiovascular risk. This state of affairs is attributable to the fact that the tools used for diagnosis or treatment are still those that originated in the 1970-1990s. Conversely, molecular discoveries have transformed our understanding of adrenal physiology and pathology. Many molecules and processes associated with constant adrenocortical renewal and interzonal metamorphosis also feature in aldosterone-producing adenomas and aldosterone-producing micronodules. The adrenal gland has one of the most significant rates of non-silent somatic mutations, with frequent selection of those driving autonomous aldosterone production, and distinct clinical presentations and outcomes for most genotypes. The disappearance of aldosterone synthesis and cells from most of the adult human zona glomerulosa is the likely driver of the mutational success that causes aldosterone-producing adenomas, but insights into the pathways that lead to constitutive aldosterone production and cell survival may open up opportunities for novel therapies.

摘要

原醛症是高血压最常见的单一病因,当仅一个肾上腺是罪魁祸首时,其具有潜在可治愈性。尽管常规治疗控制血压不佳且心血管风险增加,但由于公众健康对原醛症的认识不足,其巨大的漏诊率(估计不到所有受影响个体的 1%)仍令人担忧。这种情况归因于用于诊断或治疗的工具仍然是那些起源于 20 世纪 70 年代至 90 年代的工具。相反,分子发现改变了我们对肾上腺生理学和病理学的理解。许多与肾上腺皮质不断更新和区域间变形相关的分子和过程也存在于产生醛固酮的腺瘤和产生醛固酮的微结节中。肾上腺具有最高的非沉默体细胞突变率之一,经常选择那些驱动自主醛固酮产生的突变,大多数基因型的临床表现和结果也截然不同。大多数成年人类球状带的醛固酮合成和细胞消失可能是导致产生醛固酮的腺瘤的突变成功的驱动因素,但了解导致醛固酮持续产生和细胞存活的途径可能为新的治疗方法提供机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/84ebe8bfdab0/EMS187489-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/6d8f19d51289/EMS187489-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/a071d22361e9/EMS187489-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/53910ecad93e/EMS187489-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/dc26716f33f7/EMS187489-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/ffe21f11b5cf/EMS187489-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/84ebe8bfdab0/EMS187489-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/6d8f19d51289/EMS187489-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/a071d22361e9/EMS187489-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/53910ecad93e/EMS187489-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/dc26716f33f7/EMS187489-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/ffe21f11b5cf/EMS187489-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff6e/7615304/84ebe8bfdab0/EMS187489-f006.jpg

相似文献

1
Primary aldosteronism: molecular medicine meets public health.原发性醛固酮增多症:分子医学与公共卫生的交汇。
Nat Rev Nephrol. 2023 Dec;19(12):788-806. doi: 10.1038/s41581-023-00753-6. Epub 2023 Aug 23.
2
[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].基于187例原发性醛固酮增多症的回顾性分析的诊断与治疗结果
Orv Hetil. 2006 Jan 15;147(2):51-9.
3
Diagnosis and treatment of primary aldosteronism.原发性醛固酮增多症的诊断与治疗。
Lancet Diabetes Endocrinol. 2021 Dec;9(12):876-892. doi: 10.1016/S2213-8587(21)00210-2.
4
Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling.由多个肾上腺皮质微结节引起的单侧醛固酮增多症的罕见病例,只能通过选择性肾上腺静脉采血检测到。
Metabolism. 2002 Mar;51(3):350-5. doi: 10.1053/meta.2002.30498.
5
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.原发性醛固酮增多症和醛固酮瘤的遗传学研究进展。
Curr Cardiol Rep. 2022 Sep;24(9):1189-1195. doi: 10.1007/s11886-022-01735-z. Epub 2022 Jul 16.
6
Novel genetic determinants of adrenal aldosterone regulation.肾上腺醛固酮调节的新型遗传决定因素。
Curr Opin Endocrinol Diabetes Obes. 2016 Jun;23(3):209-17. doi: 10.1097/MED.0000000000000255.
7
Transcriptome Pathway Analysis of Pathological and Physiological Aldosterone-Producing Human Tissues.病理性和生理性醛固酮生成人类组织的转录组通路分析
Hypertension. 2016 Dec;68(6):1424-1431. doi: 10.1161/HYPERTENSIONAHA.116.08033. Epub 2016 Oct 24.
8
Disordered CYP11B2 Expression in Primary Aldosteronism.原发性醛固酮增多症中CYP11B2表达紊乱
Horm Metab Res. 2017 Dec;49(12):957-962. doi: 10.1055/s-0043-122238. Epub 2017 Dec 4.
9
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.对高血压患者进行“非选择性”筛查后,原发性醛固酮增多症(包括可手术治疗的类型)的检出率很高。
J Hypertens. 2003 Nov;21(11):2149-57. doi: 10.1097/00004872-200311000-00025.
10
Pathology of Aldosterone Biosynthesis and its Action.醛固酮生物合成及其作用的病理学
Tohoku J Exp Med. 2021 May;254(1):1-15. doi: 10.1620/tjem.254.1.

引用本文的文献

1
Editorial: Adrenal related hypertension: from bench to bedside, volume II.社论:肾上腺相关性高血压:从实验室到临床,第二卷
Front Endocrinol (Lausanne). 2025 Jul 3;16:1647120. doi: 10.3389/fendo.2025.1647120. eCollection 2025.
2
Mild autonomous cortisol secretion in primary aldosteronism: the origin of cortisol.原发性醛固酮增多症中的轻度自主性皮质醇分泌:皮质醇的来源
Hypertens Res. 2025 Jun 3. doi: 10.1038/s41440-025-02245-5.
3
Multiomics analysis unveils the cellular ecosystem with clinical relevance in aldosterone-producing adenomas with mutations.

本文引用的文献

1
Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production.醛固酮瘤中 CADM1 的体细胞突变和缝隙连接依赖性的醛固酮产生调节。
Nat Genet. 2023 Jun;55(6):1009-1021. doi: 10.1038/s41588-023-01403-0. Epub 2023 Jun 8.
2
Accuracy of Gallium-68 Pentixafor Positron Emission Tomography-Computed Tomography for Subtyping Diagnosis of Primary Aldosteronism.镓-68 吡咯烷酮[¹¹C]戊烷多靶素正电子发射断层扫描-计算机断层扫描用于原发性醛固酮增多症的亚型诊断的准确性。
JAMA Netw Open. 2023 Feb 1;6(2):e2255609. doi: 10.1001/jamanetworkopen.2022.55609.
3
[C]metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial.
多组学分析揭示了在伴有突变的醛固酮瘤中具有临床相关性的细胞生态系统。
Proc Natl Acad Sci U S A. 2025 Mar 4;122(9):e2421489122. doi: 10.1073/pnas.2421489122. Epub 2025 Feb 26.
4
Meriones unguiculatus serves as a spontaneous primary aldosteronism rodent model.长爪沙鼠可作为原发性醛固酮增多症的自发性啮齿动物模型。
PLoS One. 2025 Feb 13;20(2):e0314943. doi: 10.1371/journal.pone.0314943. eCollection 2025.
5
ccfDNA analysis for the classification of adrenocortical adenomas.用于肾上腺皮质腺瘤分类的循环游离DNA分析
J Endocrinol Invest. 2025 May;48(5):1207-1216. doi: 10.1007/s40618-025-02540-5. Epub 2025 Feb 1.
6
Beyond pharmacotherapy: bilateral adrenal artery embolization as a potential game-changer for idiopathic hyperaldosteronism patients.超越药物治疗:双侧肾上腺动脉栓塞术可能成为原发性醛固酮增多症患者的治疗变革手段
Hypertens Res. 2025 Jan;48(1):414-416. doi: 10.1038/s41440-024-01984-1. Epub 2024 Nov 14.
7
Exploration of the shared gene signatures and comorbidity mechanisms of primary aldosteronism and atrial fibrillation.原发性醛固酮增多症与心房颤动的共享基因特征及共病机制探索
Endocr Connect. 2024 Dec 19;14(1). doi: 10.1530/EC-24-0402. Print 2025 Jan 1.
8
The effect of adrenalectomy on bleomycin-induced pulmonary fibrosis in mice.肾上腺切除术对博来霉素诱导的小鼠肺纤维化的影响。
Am J Physiol Lung Cell Mol Physiol. 2025 Jan 1;328(1):L15-L29. doi: 10.1152/ajplung.00062.2024. Epub 2024 Oct 29.
9
Somatic , , and Mutations in Cat Aldosterone-Secreting Tumors.猫醛固酮分泌肿瘤中的体细胞、胚系和种系突变。
Hypertension. 2024 Dec;81(12):2489-2500. doi: 10.1161/HYPERTENSIONAHA.124.23501. Epub 2024 Oct 21.
10
Hypertension research 2024 update and perspectives: basic research.《高血压研究2024年最新进展与展望:基础研究》
Hypertens Res. 2024 Dec;47(12):3304-3309. doi: 10.1038/s41440-024-01878-2. Epub 2024 Sep 9.
美替拉酮 PET-CT 与肾上腺静脉取样用于诊断可手术治愈的原发性醛固酮增多症:一项前瞻性、患者内试验。
Nat Med. 2023 Jan;29(1):190-202. doi: 10.1038/s41591-022-02114-5. Epub 2023 Jan 16.
4
Loss of LGR4/GPR48 causes severe neonatal salt wasting due to disrupted WNT signaling altering adrenal zonation.LGR4/GPR48 的缺失导致严重的新生儿盐耗综合征,这是由于 WNT 信号通路的破坏改变了肾上腺的分区。
J Clin Invest. 2023 Feb 15;133(4):e164915. doi: 10.1172/JCI164915.
5
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.巴多司他治疗顽固性高血压的2期试验。
N Engl J Med. 2023 Feb 2;388(5):395-405. doi: 10.1056/NEJMoa2213169. Epub 2022 Nov 7.
6
First-in-human evaluation of [F]CETO: a novel tracer for adrenocortical tumours.首个人体评估 [F]CETO:一种新型的肾上腺皮质肿瘤示踪剂。
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):398-409. doi: 10.1007/s00259-022-05957-9. Epub 2022 Sep 8.
7
Primary cilium in kidney development, function and disease.肾脏发育、功能和疾病中的初级纤毛。
Front Endocrinol (Lausanne). 2022 Aug 22;13:952055. doi: 10.3389/fendo.2022.952055. eCollection 2022.
8
Identification of risk loci for primary aldosteronism in genome-wide association studies.在全基因组关联研究中识别原发性醛固酮增多症的风险基因座。
Nat Commun. 2022 Sep 3;13(1):5198. doi: 10.1038/s41467-022-32896-8.
9
Changes of the CYP11B2 Expressing Zona Glomerulosa in Human Adrenals From Birth to 40 Years of Age.从出生到 40 岁人类肾上腺颗粒细胞层 CYP11B2 表达的变化。
Hypertension. 2022 Nov;79(11):2565-2572. doi: 10.1161/HYPERTENSIONAHA.122.19052. Epub 2022 Aug 29.
10
Safety and feasibility of radiofrequency ablation using bipolar electrodes for aldosterone-producing adenoma: a multicentric prospective clinical study.应用双极电极射频消融治疗醛固酮腺瘤的安全性和可行性:一项多中心前瞻性临床研究。
Sci Rep. 2022 Aug 18;12(1):14090. doi: 10.1038/s41598-022-18136-5.